Fundraising FoxNomos
New York, US · Founded 2022 · 3 known investors
Find your way into Nomos
Sign up to see every warm intro you have to Nomos
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nomos team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Best NOMOS designs radiation therapy planning and delivery systems for medical professionals treating cancer patients. The company specializes in innovations for intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT), serving oncology centers globally with external beam and brachytherapy solutions.
Founders & leadership
Nomos was founded in 2022 by John Nay.
Board
Investors · 3
How we know: funding news · Not right? Tell us
How we know: a partner's Signal profile · funding news · tech.eu · Not right? Tell us
Funding
SEC filings, press & company announcements$261.9M disclosed across 3 of 4 rounds · 2024–2026
- Undisclosed amountpre-seed funding roundOct 2024 · 2 sources
Speedinvest (lead)
Source ↗
▶$120MraisedJun 2026 · 19 investors · Other TechnologyRule 506(b)
- Samir KaulDirector
- Thomas MalloyExecutive Officer
- Scott WorlandExecutive Officer
- John NayExecutive Officer, Director, Promoter
- Patrick VergaraExecutive Officer
- Stevi PetrelliDirector
- Peter WallaceDirector
- Paul PasqualeExecutive Officer
- Peter ChiaroExecutive Officer
- Offering amount
- $120M
- Amount sold
- $120M
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$103.5MraisedNov 2025 · 21 investors · Other TechnologyRule 506(b)
- Stevi PetrelliDirector
- John NayExecutive Officer, Director, Promoter
- Sri ViswanathDirector
- Offering amount
- $103.5M
- Amount sold
- $103.5M
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$38.4MraisedJun 2024 · 35 investors · Other TechnologyRule 506(b)
- John NayExecutive Officer, Director, Promoter
- Sri ViswananthDirector
- Offering amount
- $38.4M
- Amount sold
- $38.4M
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Nomos do?
- Best NOMOS designs radiation therapy planning and delivery systems for medical professionals treating cancer patients. The company specializes in innovations for intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT), serving oncology centers globally with external beam and brachytherapy solutions.
- Who founded Nomos?
- Nomos was founded by John Nay in 2022.
- Who are Nomos's investors?
- Nomos's investors include Partners for Growth, Index Ventures, Speedinvest.
- How much funding has Nomos raised?
- Nomos has disclosed $261.9M raised across 3 of its 4 known rounds.
- Where is Nomos headquartered?
- Nomos is headquartered in New York, US.